Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)

BACKGROUND: Current guidelines for opioid dependence recommend daily maintenance of physical dependence with methadone or buprenorphine, and discourage abstinence due to the high risk of relapse and overdose. Extended-release formulations of the opioid antagonist naltrexone (XR-NTX) block heroin and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunøe, Nikolaj, Opheim, Arild, Solli, Kristin Klemmetsby, Gaulen, Zhanna, Sharma-Haase, Kamni, Latif, Zill-e-Huma, Tanum, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848871/
https://www.ncbi.nlm.nih.gov/pubmed/27121539
http://dx.doi.org/10.1186/s40360-016-0061-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848871/
https://www.ncbi.nlm.nih.gov/pubmed/27121539
http://dx.doi.org/10.1186/s40360-016-0061-1

Ejemplares similares